Na+1-activated and ATP-sensitive K+ channels in the heart.
Sanguinetti
M C
MC
Department of Pharmacology, Merck Sharp and Dohme Research Laboratory, West Point, PA 19486.
D000200:Action Potentials / Q000187:drug effects; D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000818:Animals; D001578:Benzopyrans / Q000494:pharmacology; D019806:Cromakalim; D005289:Ferrets; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D015640:Ion Channel Gating / Q000187:drug effects; D007700:Kinetics; D008564:Membrane Potentials / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000166:cytology / Q000378:metabolism*; D010210:Papillary Muscles / Q000187:drug effects / Q000378:metabolism; D015221:Potassium Channels / Q000187:drug effects*; D011758:Pyrroles / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology*; D013453:Sulfonylurea Compounds / Q000494:pharmacology; D013696:Temperature
D001578:Benzopyrans; D015221:Potassium Channels; D011758:Pyrroles; D013453:Sulfonylurea Compounds; D019806:Cromakalim; D000255:Adenosine Triphosphate; D012964:Sodium